San Francisco, 12 June 2024: The Report Regenerative Medicine Market Size, Share & Trends Analysis Report By Product (Cell-based Immunotherapies, Gene Therapies), By Therapeutic Category, By Region, And Segment Forecasts, 2024 – 2030

The increasing awareness regarding advanced medical therapies supports the global regenerative medicine market demand. In addition, a strong investigational pipeline of promising candidates and expected approvals in the coming years are projected to favor market expansion. Furthermore, advancements in nanotechnology and the increasing prevalence of degenerative disorders have emphasized research to introduce novel regenerative therapies.

Recent advancements in biological therapies have resulted in a gradual shift in preference toward personalized medicinal strategies over the conventional treatment approach. This has created opportunities for companies that are involved in the development of biological therapeutics. Furthermore, the rise in the incidence of degenerative disorders has led to an increase in focus on research to discover novel regenerative therapies.

According to a study by Grand View Research, in 2023, the global market size of regenerative medicine was valued at USD 30.4 billion and is anticipated to expand at a CAGR of 16.8% from 2024 to 2030. Regenerative medicines have the exceptional ability to modify the elemental mechanisms of diseases. Regenerative therapies in trials deliver favorable resolutions for certain chronic indications. These solutions involve the use of multiple approaches and products, such as gene therapy, tissue-engineered products, small molecules, biologics, allogeneic & autologous stem cells, and combinational products. Supportive initiatives from governments, biotechnology & pharmaceutical companies, and healthcare providers are projected to boost the industry growth.

Request sample report of Regenerative Medicine Market@ https://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market/request/rs1

The presence of a strong pipeline is one of the major drivers in the regenerative medicine market. Companies invest heavily in R&D to upgrade their products with the latest technology and fulfil the unmet needs of their customers.

Furthermore, with the increasing demand for disease treatment therapies, companies have focused their efforts to accelerate R&D for gene therapies that target the cause of disease at a genomic level. The cell and gene therapies in the U.S. pipeline programs (Phase I-III trials) grew from 289 in 2018 to 362 by 2024 according to the data published by PhRMA,. This represents an increase of 25% in a single year. Continuous advancements in this field would further boost the demand for regenerative medicines.

Regenerative Medicine Market Report Scope

Where Technology meets Medicine

Novel technologies such as tissue engineering, gene therapy, and cell-based therapies are employed in regenerative medicine to offer augmented patient care with regeneration or replacement of genes, cells, organs, & tissues in patients. The increasing applications of regenerative medicine have encouraged researchers and professionals to explore the potential of novel technologies in regenerative medicine therapeutic models. For instance, developments in the fabrication of tissue mimics & advanced grafts, technologies that can integrate grafts, and the host vasculature have been gaining traction in recent years. In addition, using immune modulation and cell injection strategies to enhance the host’s intrinsic regenerative capacity is also set to gain traction.

On the other hand, cell sheet technology is a relatively newer concept dependent on retrieving confluent cell sheets from a substrate that responds to temperature. This enables the deposition of signaling molecules, Extracellular Matrix (ECM) molecules, and cell adhesion molecules by the cells, further assisting them to remain intact. The adoption of successive layers of these sheets to develop constructs of higher thickness is presently being witnessed and is explored in corneal reconstruction.